SGO on the GO

In this podcast, we will focus on same day discharge as part of Enhanced Recovery after Surgery (ERAS). Over the past two decades, and especially after the publication of the GOG LAP2 trial, minimally invasive surgery has been widely adopted in gynecologic oncology, as it is associated with lower rates of complications, and improved postoperative recovery and return to normal activity. Postoperative hospitalization is typically shorter after minimally invasive (MIS) hysterectomy, and many patients may even be candidates for discharge on the day of surgery, so-called same-day discharge (SDD). 2023-2024 SGO ERAS Subcommittee Members and Speakers: Lee-may Chen, MD; Subcommittee Lead and Moderator Nawar Latif, MD, MPH, MSCE Clarissa Polen-De, MD Michael Shu, MD Collin Sitler, DO Brenna Swift, MD, MASc, MSc, FRCSC Diogo Torres, MD

This episode is part 2 of the Immunotherapy Series, which reviews common controversies affecting daily use of immune checkpoint inhibitors (ICIs) in the clinic, such as treatment options for immune related adverse effects beyond corticosteroids, re-challenging after toxicity, use of ICIs in patients with auto-immune conditions, and drug interactions. Moderator: Karin K. Shih, MD Gynecologic Oncologist & Assistant Professor - Zucker School of Medicine at Hofstra/Northwell Speakers: Erin Zacholski, PharmD, BCOP Assistant Professor - VCU School of Pharmacy Clinical Pharmacy Specialist, Gynecologic Oncology - VCU Health Massey Cancer Center Sarah Hayward, PharmD, BCOP Clinical Pharmacy Specialist, Gynecologic Oncology - OU Health Stephenson Cancer Center

This episode is part 3 of the Immunotherapy podcast series, which continues discussion of common controversies affecting the use of immune checkpoint inhibitors (ICIs) in the clinic, such as optimal dosing strategies, influence of toxicity on response and survival, and sequencing. Moderator: Karin K. Shih, MD Gynecologic Oncologist & Assistant Professor - Zucker School of Medicine at Hofstra/Northwell Speakers: Erin Zacholski, PharmD, BCOP Assistant Professor - VCU School of Pharmacy Clinical Pharmacy Specialist, Gynecologic Oncology - VCU Health Massey Cancer Center Sarah Hayward, PharmD, BCOP Clinical Pharmacy Specialist, Gynecologic Oncology - OU Health Stephenson Cancer Center

Join Dr. Robert Neff as he interviews Drs. Kathleen Moore and Charles Leath, III to discuss the latest NRG Oncology updates on upcoming studies, research, and trials. The focus for the podcast is to bridge the gaps between SGO members and NRG Oncology. Some questions covered during the interview: This episode was created by Dr. Robert Neff, 2023-2024 member of the SGO Education Committee's Clinical Trials Management/Concepts Subcommittee. Thanks to Drs. Moore and Leath, III for your contribution to this episode. Moderator: Robert Neff, MD Speakers: Kathleen Moore, MD Charles Leath, III, MD

Episode three of the Radiation Therapy podcast series discusses radiation techniques and management with regard to locally advanced cervical cancer. Host/Moderator: Leigh A. Cantrell, MD, MSPH Professor, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology - University of Virginia Guest Speaker: Kara Romano, M.D. Assistant Professor, Department of Radiation Oncology - University of Virginia

Join Dr. Janelle Darby, member of the SGO Clinical Trials Management/Concepts Subcommittee, as she interviews Drs. Evan Graboyes, Jeffrey Hines, and Bhavana Pothuri, addressing continued efforts to improve inclusion of racially and ethnically diverse patients in clinical trials. Some topics covered during the interview: 2023-2024 SGO Clinical Trials Management/Concepts Subcommittee Member and Moderator: Janelle Pakish Darby, MD Speakers: Evan Graboyes, MD, MPH, FACS Jeffrey Hines, MD Bhavana Pothuri, MD, MS

This podcast focuses on the surgical site infection reduction bundle as part of the ERAS guidelines that was first published in 2016 and updated in 2019, and the 2020 vulvar and vaginal surgeries ERAS guidelines. Before we dive into the SSI reduction bundle, we want to highlight the importance of patient education and participation in any ERAS protocol. Pre-operative education and psychological preparation is critical. Written information was determined to be superior to verbal in a randomized clinical trial in gynecologic oncology surgery. 2023-2024 SGO ERAS Subcommittee Members and Speakers: Lee-may Chen, MD; Subcommittee Lead and Moderator Nawar Latif, MD, MPH, MSCE Collin Sitler, DO Brenna Swift, MD, MASc, MSc, FRCSC

This is the first of the three-part podcast series, Keeping up with the Chemos on Trabectedin and Doxorubicin. After going over some general information on Trabectedin and Doxorubicin including when to use the drug, checking patient performance status, toxicity, and line of therapy and treatment option for recurring metastasis disease. The multidisciplinary panel will discuss dosing and drug preparation for giving Trabectedin and Doxorubicin. The session wraps up with some key take home points on Trabectedin and Doxorubicin. 2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators: Tracilyn Hall, MD Jennifer MacDonald, PharmD, BCOP Speakers: Sminu Bose, MD Joshua Cohen, MD Claire Marie Mach, PharmD, BCOP

This is the second of the three-part podcast series, Keeping up with the Chemos on Trabectedin and Doxorubicin. Our multidisciplinary panel will discuss the important information about the drug preparation and administration of Trabectedin and Doxorubicin. Focusing on oral dosing, infusion pump setup, lab examinations, and patient education. The session ends with general take home points on administration and toxicity prevention interventions. 2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators: Tracilyn Hall, MD Jennifer MacDonald, PharmD, BCOP Speakers: Sminu Bose, MD Joshua Cohen, MD Claire Marie Mach, PharmD, BCOP

This is the last of the three-part podcast series, Keeping up with the Chemos on Trabectedin and Doxorubicin. Our multidisciplinary panel will discuss the challenges with patient monitoring while on Trabectedin and Doxorubicin. When to dose adjust and hold or even discontinue Trabectedin and Doxorubicin. Once again, the podcast ends with take home points for patient monitoring and side effects while on Trabectedin and Doxorubicin. 2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators: Tracilyn Hall, MD Jennifer MacDonald, PharmD, BCOP Speakers: Sminu Bose, MD Joshua Cohen, MD Claire Marie Mach, PharmD, BCOP

Episode two of the Radiation Therapy podcast series discusses treatment of Oligometastatic disease, re-irradiation and role of palliative radiation, utilization of SBRT, introduction to proton therapy and mitigation of radiation-associated toxicities. Host: Mian M. Shahzad, MD, PhD Gynecologic Oncologist, H. Lee Moffitt Cancer Center Guest Speaker: Michael Montejo, MD Radiation oncologist, H. Lee Moffitt Cancer Center

This episode is part 1 of the Immunotherapy podcast series, which reviews immune-checkpoint inhibitors encountered in the gynecologic oncology setting, common immunotherapy toxicities and patient counseling on them, as well as the basic treatment course for patients with high-grade toxicities. Moderator: Karin K. Shih, MD Gynecologic Oncologist & Assistant Professor - Zucker School of Medicine at Hofstra/Northwell Speakers: Erin Zacholski, PharmD, BCOP Assistant Professor - VCU School of Pharmacy Clinical Pharmacy Specialist, Gynecologic Oncology - VCU Health Massey Cancer Center Sarah Hayward, PharmD, BCOP Clinical Pharmacy Specialist, Gynecologic Oncology - OU Health Stephenson Cancer Center

This episode is part 1 of the Radiation Therapy podcast series, which looks to review and address the basic fundamentals of radiation therapy in the gynecologic oncology setting. Host: Mian M. Shahzad, MD PhD (Gynecologic Oncologist; H. Lee Moffitt Cancer Center) Guest Speaker: Michael Montejo, MD (Radiation oncologist; H. Lee Moffitt Cancer Center)

This is the first of the three-part podcast series, Keeping up with the Chemos on Trametinib. After going over some general information on Trametinib including mutation status considerations, baseline lab testing, ocular toxicity, and line of therapy. The multidisciplinary panel will discuss dosing and drug preparation for giving Trametinib. The session wraps up with some key take home points on Trametinib. 2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators: Tracilyn Hall, MD Jennifer MacDonald, PharmD, BCOP Speakers: Christina M. Davis, PharmD, BCOP David M. Gershenson, MD Rebecca L. Porter, MD, PhD

This is the second of the three-part podcast series, Keeping up with the Chemos on Trametinib. Our multidisciplinary panel will discuss the important information about the drug preparation and administration of Trametinib. Focusing on oral dosing, lab examinations, prophylactic management of skincare reactions, and patient education. The session ends with general take home points on administration and toxicity prevention interventions. 2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators: Tracilyn Hall, MD Jennifer MacDonald, PharmD, BCOP Speakers: Christina M. Davis, PharmD, BCOP David M. Gershenson, MD Rebecca L. Porter, MD, PhD

This is the last of the three-part podcast series, Keeping up with the Chemos on Trametinib. Our multidisciplinary panel will discuss the challenges with patient monitoring while on Trametinib. When to dose adjust and hold or even discontinue Trametinib. Once again, the podcast ends with take home points for patient monitoring and side effects while on Trametinib. 2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators: Tracilyn Hall, MD Jennifer MacDonald, PharmD, BCOP Speakers: Christina M. Davis, PharmD, BCOP David M. Gershenson, MD Rebecca L. Porter, MD, PhD

The goal of this podcast is to continue our series on key concepts of enhanced recovery after surgery (ERAS). In September 2022, the SGO Education Committee's ERAS Subcommittee discussed why we do it, and in February 2023, we talked about how we do it. This podcast will complete our trilogy and discuss implementation or looking at how well we do it. Listen to Gregg Nelson, MD, PhD from the University of Calgary discuss ERAS implementation including some of the starting points, his experience in his own institution, and key ERAS lessons learned. Dr. Nelson is the Deputy Head of the Department of Obstetrics & Gynecology at the Cumming School of Medicine in Calgary, Alberta, Canada and is Chief of Gynecologic Oncology at the Tom Baker Cancer Centre. He is also on the Executive Committee for the international ERAS® Society, and a lead author for the ERAS® Society gynecologic guidelines. 2023-2024 ERAS Subcommittee Moderator and Podcast Script Editor: Lee-may Chen, MD 2022-2023 Opioid/ERAS Subcommittee Members: Jing-Yi Chern, MD (Moderator) Amanika Kumar, MD (Podcast Script Editor) Podcast Invited Speaker: Gregg Nelson, MD, PhD

Let’s face it, wellness is an ever-evolving concept. Listen in as we celebrate aspects of wellness throughout the SGO community. These are 10–20-minute quarterly snippets to highlight the authentic voices from SGO and beyond. Stay connected and foster community in between SGO meetings. You can find these episodes anywhere you get your SGO on the Go podcasts. To view the SGO Wellness Curriculum, click here.

Join Dr. Kathryn Mills as she interviews Drs. Jubilee Brown, Ann Klopp, Joyce Liu, and Jyoti Mayadev to discuss the latest NRG Oncology updates on upcoming studies, research, and trials. The focus for the podcast is to bridge the gaps between SGO members and NRG Oncology. Some questions covered during the interview: This episode was created by Dr. Kathryn Mills, a former 2022-2023 member of the SGO Education Committee's Clinical Trials Management/Concepts Subcommittee. Thanks to Drs. Jubilee Brown, Ann Klopp, Joyce Liu, and Jyoti Mayadev for your contribution to this episode. Moderator: Kathryn Mills, MD Speakers: Jubilee Brown, MD Ann Klopp, MD, PhD Joyce Liu, MD, MPH Jyoti Mayadev, MD

This is the first of the three-part podcast series, Keeping up with the Chemos on Mirvetuximab soravtansine. After going over some general information on Mirvetuximab soravtansine including mechanism of action and indication. The multidisciplinary panel will discuss the aspects of getting a team of APP, Optometrist, and Gynecologic Oncologist educated and prepared for giving Mirvetuximab soravtansine. The session wraps up with some key take home points on Mirvetuximab soravtansine. 2022-2023 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators: Tracilyn Hall, MD Judith A. Smith, B.S., Pharm.D, BCOP, CPHQ Speakers: Julia Canestraro, OD, FAAO Karen Lyle, PA-C Kathleen Moore, MD